Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven Mathieu is active.

Publication


Featured researches published by Steven Mathieu.


Molecular Cancer Therapeutics | 2016

Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61.

Kuan-Chun Huang; Zhihong Chen; Yimin Jiang; Sandeep Akare; Donna Kolber-Simonds; Krista Condon; Sergei Agoulnik; Karen TenDyke; Yongchun Shen; Kuo-Ming Wu; Steven Mathieu; Hyeong-wook Choi; Xiaojie Zhu; Hajime Shimizu; Yoshihiko Kotake; William H. Gerwick; Toshimitsu Uenaka; Mary Woodall-Jappe; Kenichi Nomoto

Apratoxin A is a natural product with potent antiproliferative activity against many human cancer cell lines. However, we and other investigators observed that it has a narrow therapeutic window in vivo. Previous mechanistic studies have suggested its involvement in the secretory pathway as well as the process of chaperone-mediated autophagy. Still the link between the biologic activities of apratoxin A and its in vivo toxicity has remained largely unknown. A better understanding of this relationship is critically important for any further development of apratoxin A as an anticancer drug. Here, we describe a detailed pathologic analysis that revealed a specific pancreas-targeting activity of apratoxin A, such that severe pancreatic atrophy was observed in apratoxin A–treated animals. Follow-up tissue distribution studies further uncovered a unique drug distribution profile for apratoxin A, showing high drug exposure in pancreas and salivary gland. It has been shown previously that apratoxin A inhibits the protein secretory pathway by preventing cotranslational translocation. However, the molecule targeted by apratoxin A in this pathway has not been well defined. By using a 3H-labeled apratoxin A probe and specific Sec 61α/β antibodies, we identified that the Sec 61 complex is the molecular target of apratoxin A. We conclude that apratoxin A in vivo toxicity is likely caused by pancreas atrophy due to high apratoxin A exposure. Mol Cancer Ther; 15(6); 1208–16. ©2016 AACR.


Angewandte Chemie | 2015

Stereoselective Synthesis of the Halaven C14–C26 Fragment from D-Quinic Acid: Crystallization-Induced Diastereoselective Transformation of an α-Methyl Nitrile†

Francis Belanger; Charles E. Chase; Atsushi Endo; Francis G. Fang; Jing Li; Steven Mathieu; Annie Z. Wilcoxen; Huiming Zhang

Crystallization-induced diastereoselective transformation (CIDT) of an α-methyl nitrile completes an entirely non-chromatographic synthesis of the halichondrin B C14-C26 stereochemical array. The requisite α-methyl nitrile substrate is derived from D-quinic acid through a series of substrate-controlled stereoselective reactions via a number of crystalline intermediates that benefit from a rigid polycyclic template. Therefore, all four stereogenic centers in the Halaven C14-C26 fragment were derived from the single chiral source D-quinic acid.


Organic Letters | 2017

Prins Reaction of Homoallenyl Alcohols: Access to Substituted Pyrans in the Halichondrin Series

Hyeong-wook Choi; Francis G. Fang; Hui Fang; Dae-Shik Kim; Steven Mathieu; Robert T. Yu

Prins reaction of homoallenyl alcohols with aldehyde dimethylacetals in the presence of methoxyacetic acid directly affords tetrasubstituted pyrans relevant to halichondrins with complete control of the C27 stereogenic center. Regioselective Tsuji reduction of the resultant allylic acetates stereoselectively establishes the C25 stereogenic center and C26 exocyclic olefin. Building upon these findings, we achieved concise access to the halichondrin C14-C38 and eribulin C14-C35 fragments.


Archive | 2013

Salt form of a human histone methyltransferase ezh2 inhibitor

Kevin Wayne Kuntz; Kuan-Chun Huang; Hyeong Wook Choi; Kristen Sanders; Steven Mathieu; Arani Chanda; Frances Fang


Archive | 2016

HYDROCHLORIDE SALT FORM FOR EZH2 INHIBITION

Kevin Wayne Kuntz; Hyeong-wook Choi; Steven Mathieu; Kristen Sanders; Arani Chanda


Archive | 2015

STEREOCHEMICALLY DEFINED POLYPROPIONATES AND METHODS FOR MAKING AND USING THE SAME

Francis G. Fang; Hyeong-wook Choi; Silvio Campagna; Steven Mathieu


Angewandte Chemie | 2015

Inside Cover: Stereoselective Synthesis of the Halaven C14–C26 Fragment from D‐Quinic Acid: Crystallization‐Induced Diastereoselective Transformation of an α‐Methyl Nitrile (Angew. Chem. Int. Ed. 17/2015)

Francis Belanger; Charles E. Chase; Atsushi Endo; Francis G. Fang; Jing Li; Steven Mathieu; Annie Z. Wilcoxen; Huiming Zhang


Tetrahedron Letters | 2014

A green bromination process for synthesis of a novel drug candidate

Steven Mathieu; George A. Moniz


Archive | 2013

Forme saline d'un inhibiteur de l'histone méthyltransférase humaine ezh2

Kevin Wayne Kuntz; Kuan-Chun Huang; Hyeong Wook Choi; Kristen Sanders; Steven Mathieu; Arani Chanda; Frank Fang


Archive | 2013

Salt form histone methyltransferase inhibitor EZH2 human

Kevin Wayne Kuntz; Kuan-Chun Huang; Hyeong Wook Choi; Kristen Sanders; Steven Mathieu; Arani Chanda; Frank Fang

Collaboration


Dive into the Steven Mathieu's collaboration.

Researchain Logo
Decentralizing Knowledge